Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Microflora Disturbance during Progression of Glucose Intolerance and Effect of Sitagliptin: An Animal Study
Xinfeng Yan, Bo Feng, Peicheng Li, et al.
Journal of Diabetes Research (2016) Vol. 2016, pp. 1-10
Open Access | Times Cited: 96

Showing 1-25 of 96 citing articles:

Oral administration of Blautia wexlerae ameliorates obesity and type 2 diabetes via metabolic remodeling of the gut microbiota
Koji Hosomi, Mayu Saito, Jonguk Park, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 234
Xiexin Tang improves the symptom of type 2 diabetic rats by modulation of the gut microbiota
Xiaoyan Wei, Jinhua Tao, Suwei Xiao, et al.
Scientific Reports (2018) Vol. 8, Iss. 1
Open Access | Times Cited: 225
Inulin-type fructan improves diabetic phenotype and gut microbiota profiles in rats
Qian Zhang, Hongyue Yu, Xinhua Xiao, et al.
PeerJ (2018) Vol. 6, pp. e4446-e4446
Open Access | Times Cited: 164
Gut microbiota in the pathogenesis and therapeutic approaches of diabetes
Lucilla Crudele, Raffaella Maria Gadaleta, Marica Cariello, et al.
EBioMedicine (2023) Vol. 97, pp. 104821-104821
Open Access | Times Cited: 88
Drug-microbiota interactions: an emerging priority for precision medicine
Qing Zhao, Yao Chen, Weihua Huang, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 79
Polyphenols synergistic drugs to ameliorate non-alcoholic fatty liver disease via signal pathway and gut microbiota: A review
Hongcai Li, Jingjing Liang, Mengzhen Han, et al.
Journal of Advanced Research (2024)
Open Access | Times Cited: 17
Considering gut microbiota in treatment of type 2 diabetes mellitus
Aneseh Adeshirlarijaney, Andrew T. Gewirtz
Gut Microbes (2020) Vol. 11, Iss. 3, pp. 253-264
Open Access | Times Cited: 121
Effects of Antidiabetic Drugs on Gut Microbiota Composition
Sophie A. Montandon, François R. Jornayvaz
Genes (2017) Vol. 8, Iss. 10, pp. 250-250
Open Access | Times Cited: 119
Arachidonic acid in health and disease with focus on hypertension and diabetes mellitus: A review
Undurti N. Das
Journal of Advanced Research (2018) Vol. 11, pp. 43-55
Open Access | Times Cited: 108
Coix seed polysaccharides alleviate type 2 diabetes mellitus via gut microbiota-derived short-chain fatty acids activation of IGF1/PI3K/AKT signaling
Ting Xia, Chang‐Shun Liu, Yan‐Nan Hu, et al.
Food Research International (2021) Vol. 150, pp. 110717-110717
Closed Access | Times Cited: 102
Bi-directional drug-microbiome interactions of anti-diabetics
Andrew Whang, Ravinder Nagpal, Hariom Yadav
EBioMedicine (2018) Vol. 39, pp. 591-602
Open Access | Times Cited: 98
Chronic chlorpyrifos exposure elicits diet-specific effects on metabolism and the gut microbiome in rats
Bing Fang, Jinwang Li, Ming Zhang, et al.
Food and Chemical Toxicology (2017) Vol. 111, pp. 144-152
Closed Access | Times Cited: 93
A Purified Anthraquinone-Glycoside Preparation From Rhubarb Ameliorates Type 2 Diabetes Mellitus by Modulating the Gut Microbiota and Reducing Inflammation
Hong‐Xin Cui, Ling-Shuai Zhang, Yang Luo, et al.
Frontiers in Microbiology (2019) Vol. 10
Open Access | Times Cited: 78
Probiotics supplementation and insulin resistance: a systematic review
Bárbara Izabel Moraes Salles, Débora Cioffi, Sandra Roberta G. Ferreira
Diabetology & Metabolic Syndrome (2020) Vol. 12, Iss. 1
Open Access | Times Cited: 76
Flavonoids on diabetic nephropathy: advances and therapeutic opportunities
Qichao Hu, Caiyan Qu, Xiaolin Xiao, et al.
Chinese Medicine (2021) Vol. 16, Iss. 1
Open Access | Times Cited: 74
The role of the gut microbiota in health and cardiovascular diseases
Lu Wang, Shiqi Wang, Qing Zhang, et al.
Molecular Biomedicine (2022) Vol. 3, Iss. 1
Open Access | Times Cited: 67
Regulating the gut microbiota and SCFAs in the faeces of T2DM rats should be one of antidiabetic mechanisms of mogrosides in the fruits of Siraitia grosvenorii
Yulong Zhang, Ying Peng, Lijuan Zhao, et al.
Journal of Ethnopharmacology (2021) Vol. 274, pp. 114033-114033
Closed Access | Times Cited: 59
The Relationships between Gut Microbiota and Diabetes Mellitus, and Treatments for Diabetes Mellitus
Cristian-Ioan Crăciun, Maria Adriana Neag, Adrian Cătinean, et al.
Biomedicines (2022) Vol. 10, Iss. 2, pp. 308-308
Open Access | Times Cited: 51
Type 2 diabetes, gut microbiome, and systems biology: A novel perspective for a new era
Yoscelina Estrella Martínez-López, Diego Esquivel-Hernández, Jean Paul Sánchez-Castañeda, et al.
Gut Microbes (2022) Vol. 14, Iss. 1
Open Access | Times Cited: 40
Gut Microbiota and Antidiabetic Drugs: Perspectives of Personalized Treatment in Type 2 Diabetes Mellitus
Wenhui Liu, Zhiying Luo, Jiecan Zhou, et al.
Frontiers in Cellular and Infection Microbiology (2022) Vol. 12
Open Access | Times Cited: 38
Gut microbiota and therapy for obesity and type 2 diabetes
Luyao Zhang, Pai Wang, Juan Huang, et al.
Frontiers in Endocrinology (2024) Vol. 15
Open Access | Times Cited: 15
Effects of metformin, acarbose, and sitagliptin monotherapy on gut microbiota in Zucker diabetic fatty rats
Minchun Zhang, Rilu Feng, Mei Yang, et al.
BMJ Open Diabetes Research & Care (2019) Vol. 7, Iss. 1, pp. e000717-e000717
Open Access | Times Cited: 73
Perilla oil regulates intestinal microbiota and alleviates insulin resistance through the PI3K/AKT signaling pathway in type-2 diabetic KKAy mice
Jiankang Wang, Yutong He, Deqing Yu, et al.
Food and Chemical Toxicology (2019) Vol. 135, pp. 110965-110965
Closed Access | Times Cited: 73
Gut microbiota, hypertension and chronic kidney disease: Recent advances
Antonio Sircana, Franco De Michieli, Renato Parente, et al.
Pharmacological Research (2018) Vol. 144, pp. 390-408
Closed Access | Times Cited: 71
Alteration of gut microbiota induced by DPP-4i treatment improves glucose homeostasis
Xiaoyu Liao, Lingyu Song, Benhua Zeng, et al.
EBioMedicine (2019) Vol. 44, pp. 665-674
Open Access | Times Cited: 70
Page 1 - Next Page

Scroll to top